Peter Marks, CBER director (Greg Nash/Pool via AP Images)

Eye in­jec­tions caus­ing blind­ness? FDA’s stem cell clin­ic crack­down read­ies for ac­tion

Be­gin­ning next week, the FDA will of­fi­cial­ly start a long-await­ed crack­down on stem cell clin­ics hawk­ing un­proven treat­ments that have no in­ten­tion of go­ing through the of­fi­cial process of test­ing their prod­ucts in clin­i­cal tri­als.

More than 1,000 of these di­rect-to-con­sumer stem cell clin­ics have popped up across the coun­try in re­cent years, promis­ing help for con­di­tions with lim­it­ed to no treat­ment op­tions, like Alzheimer’s, ALS, autism or even Covid-19, and no clin­i­cal ev­i­dence to back their pricey prod­ucts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.